BioVaxys Technology (BioVaxys Technology) Other Operating Expense : $0.56 Mil (TTM As of Jul. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Other Operating Expense?

BioVaxys Technology's Other Operating Expense for the three months ended in Jul. 2023 was $0.17 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jul. 2023 was $0.56 Mil.

BioVaxys Technology's quarterly Other Operating Expense increased from Jan. 2023 ($0.16 Mil) to Apr. 2023 ($0.19 Mil) but then declined from Apr. 2023 ($0.19 Mil) to Jul. 2023 ($0.17 Mil).

BioVaxys Technology's annual Other Operating Expense increased from Oct. 2020 ($0.07 Mil) to Oct. 2021 ($0.37 Mil) but then declined from Oct. 2021 ($0.37 Mil) to Oct. 2022 ($0.21 Mil).

BioVaxys Technology Other Operating Expense Historical Data

The historical data trend for BioVaxys Technology's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Other Operating Expense Chart

BioVaxys Technology Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

Other Operating Expense

0.03

0.07

0.37

0.21

BioVaxys Technology Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Other Operating Expense	Get a 7-Day Free Trial															0.06	0.04	0.16	0.19	0.17

BioVaxys Technology Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.56 Mil.

BioVaxys Technology Other Operating Expense Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BioVaxys Technology (BioVaxys Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

5LB:Germany BIOV:Canada

Address

146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4

Website

https://www.biovaxys.com

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.